Sirt6

Does SIRT6 hold the key to human longevity?

Biotech

SIRT6-focused biotech cements longevity focus with heavyweight appointment

Economy Investment Investment

Genflow builds on SIRT6 research with new patent

Biotech Investment

Genflow Bio scoops €250k to accelerate antiaging gene therapy platform

Biotech Investment

Longevity sirtuin clinical trial teases promising results

Supplements

Genflow Bio set to accelerate future therapeutic developments

Biotech Investment

Genflow Biosciences moves into cellular reprogramming

Biotech

Genflow collaborates with Aging Research Centre to drive sirtuin research

Biotech Investment

Genflow receives grant award to accelerate longevity research

Investment